ATM and cancer: Our study showed higher mutation load in patients carrying ATM/RB1 mutations in the combined datasets, suggesting the correlation between DNA repair defect and mutation burden may still be present in sporadic cancers as a result of increased genomic instability through loss of DSB DNA repair.